- Riley Group Research Group
D.Phil. / PhD
Postdoctoral Research Scientist
Identifying drugs to stimulate endogenous cardiac progenitor cells for heart regeneration after infarction
Sophia Malandraki-Miller studied Applied Biology & Biotechnology at University of Ioannina, in Greece.
She then completed her PhD studies in Department of Physiology, Anatomy & Genetics - University of Oxford in Prof. C. Carr's group. Her research was conducted on cardiac progenitor cells (isolation methods, metabolism, differentiation, and miRNA pre-conditioning) and stem cell therapy.
In 2017 she started as a Postdoctoral Research Scientist in Prof. Paul Riley’s group at DPAG, jointly working for Oxstem, a University of Oxford spin-out focusing on stem cell drug discovery.
She is currently investigating the activation of adult endogenous epicardial progenitor cells, using small molecules, with the ultimate goal to treat myocardial infarction.